Adicet Bio, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Adicet Bio, Inc. (ACET), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are ACET insiders buying or selling?
In the last 12 months, Adicet Bio, Inc. insiders reported 2 open-market purchases ($6.6M) and 1 sale ($674.8K) — net buying of $5.9M. Since January 2018, Trabud has recorded 50 Form 4 filings for ACET: 15 buys ($58.8M) and 35 sells ($16.9M).
Source: SEC EDGAR Form 4
Key Statistics (January 2018 – Apr 13, 2026)
Total Form 4 filings
50
SEC EDGAR
Insider filers
13
Insider buys (15)
$58.8M
Insider sells (35)
$16.9M
Insider sentiment
Net buyingNet insider flow of $41.9M in net buying since January 2018, and $5.9M in net buying over the last 12 months.
Recent ACET insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Peter Kolchinsky | 10% Owner | Purchase | 223.6K | $7.17 | $1.6M | SEC ↗ |
| Apr 9, 2026 | ORBIMED ADVISORS LLC | 10% Owner | Sale | 104.7K | $6.45 | $674.8K | SEC ↗ |
| Oct 11, 2025 | ORBIMED ADVISORS LLC | 10% Owner | Purchase | 5.0M | $1.00 | $5.0M | SEC ↗ |
| Jun 7, 2024 | Michael Kauffman | Director | Sale | 5.9K | $1.43 | $8.4K | SEC ↗ |
| Jan 27, 2024 | ORBIMED ADVISORS LLC | Director, 10% Owner | Purchase | 3.1M | $2.40 | $7.5M | SEC ↗ |
| Jan 27, 2024 | Carl L Gordon | Director, 10% Owner | Purchase | 3.1M | $2.40 | $7.5M | SEC ↗ |
| Jun 30, 2023 | Steve Dubin | Director | Purchase | 5.0K | $2.40 | $12.0K | SEC ↗ |
| Jun 29, 2023 | Carl L Gordon | Director, 10% Owner | Purchase | 875.0K | $2.09 | $1.8M | SEC ↗ |
| Jun 29, 2023 | Erez Chimovits | Director, 10% Owner | Purchase | 875.0K | $2.09 | $1.8M | SEC ↗ |
| Feb 18, 2023 | Don Healey | Chief Technology Officer | Sale | 4.5K | $7.57 | $34.3K | SEC ↗ |
| Feb 14, 2023 | Don Healey | Chief Technology Officer | Sale | 10.5K | $7.98 | $83.5K | SEC ↗ |
| Nov 15, 2022 | Blake Aftab | Chief Scientific Officer | Sale | 7.0K | $21.00 | $146.3K | SEC ↗ |
| Nov 15, 2022 | Chen Schor | President & CEO | Sale | 40.0K | $20.30 | $811.2K | SEC ↗ |
| Nov 9, 2022 | Chen Schor | President & CEO | Sale | 30.0K | $19.05 | $571.5K | SEC ↗ |
| Nov 4, 2022 | Chen Schor | President & CEO | Sale | 25.3K | $18.04 | $456.7K | SEC ↗ |
| Oct 21, 2022 | Blake Aftab | Chief Scientific Officer | Sale | 8.1K | $16.27 | $131.3K | SEC ↗ |
| Oct 14, 2022 | Blake Aftab | Chief Scientific Officer | Sale | 1.6K | $15.40 | $25.3K | SEC ↗ |
| Sep 16, 2022 | Chen Schor | President & CEO | Sale | 952 | $18.00 | $17.1K | SEC ↗ |
| Sep 13, 2022 | Chen Schor | President & CEO | Sale | 78.4K | $16.80 | $1.3M | SEC ↗ |
| Aug 5, 2022 | Blake Aftab | Chief Scientific Officer | Sale | 7.0K | $18.00 | $125.4K | SEC ↗ |
| Aug 3, 2022 | Blake Aftab | Chief Scientific Officer | Sale | 7.0K | $16.64 | $115.9K | SEC ↗ |
| Jul 7, 2022 | Blake Aftab | Chief Scientific Officer | Sale | 1.4K | $14.50 | $19.8K | SEC ↗ |
| Apr 5, 2022 | Francesco Galimi | SVP & Chief Medical Officer | Sale | 15.6K | $21.00 | $327.6K | SEC ↗ |
| Mar 11, 2022 | Aya Jakobovits | Director | Sale | 4.0K | $14.00 | $56.0K | SEC ↗ |
| Feb 17, 2022 | Aya Jakobovits | Director | Sale | 4.0K | $14.83 | $59.3K | SEC ↗ |
Showing the 25 most recent of 50 Form 4 filings for Adicet Bio, Inc..
Most active ACET insiders
- Chen Schor17 filings
- Aya Jakobovits6 filings
- Blake Aftab6 filings
- ORBIMED ADVISORS LLC5 filings
- PureTech Health LLC5 filings
Ask anything about ACET insider activity
Use Trabud's AI agent to query Adicet Bio, Inc.'s Form 4 history in plain English — "Show me ACET CEO purchases this year" or compare it against any other ticker.
Open the AI agentACET insider trading FAQ
Are Adicet Bio, Inc. insiders buying or selling?
In the last 12 months, Adicet Bio, Inc. insiders reported 2 open-market purchases ($6.6M) and 1 sale ($674.8K) — net buying of $5.9M. Since January 2018, Trabud has recorded 50 Form 4 filings for ACET: 15 buys ($58.8M) and 35 sells ($16.9M). Over the full record that is net buying of $41.9M.
How many insiders trade ACET stock?
13 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Adicet Bio, Inc.. The most recent filing was accepted on Apr 13, 2026.
Where does Trabud get ACET insider trading data?
All ACET insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.